Delivery Order SPE2DB22D3501-SPE2DB25FVA79
Award Date
3/25/25
Potential Completion Date
3/26/25
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,964.50 firm fixed-price delivery order is for the supply of 4566243184 OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with a period of performance ending on October 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $5,963.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4566175299 - OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,839.00 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,775.15 firm fixed price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical product, with an ultimate completion date of November 1, 2024. AmerisourceBergen holds two relevant Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $1,789.07 firm fixed price delivery order is for 4563830856, described as OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, to be delivered by March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,943.70 firm fixed-price contract is for the delivery of 250 mcg/0.5 ml syringes of the medication Ovidrel, with a completion date of May 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This federal contract award is a $3,281.28 delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the provision of 250 mcg/0.5 mL syringes of the drug Ovidrel, with a period of performance running through December 16, 2024. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The federal contract award with ID SPE2DB22D3501|SPE2DB24FVJ38 is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,585.80 firm-fixed-price contract is for the supply of 4,564,340,496 units of the pharmaceutical product OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The award has an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) Troop Support Medical with pharmaceutical products and medical supplies, primarily in the form of firm fixed price delivery orders. The award, valued at up to $3,964.50, is for the procurement of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical. The contract has an ultimate completion date of March 22, 2024 and was awarded on March...
The federal contract award is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML medical supplies, with a ceiling value of $3,501.50. The contract was awarded on June 6, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 9, 2025 and is a firm fixed-price delivery order. The contract is not set-aside and is an open competition....